Specifically, research published in the journal suggests the Moje, Elektra and Pi2 thumb CMC joint implants may lead to poor patient outcomes. Grey Giddin, a physician in the U.K. and editor-in-chief of Journal of Hand Surgery, urges physicians to make informed and cautionary choices about implants.
“We should make a stand as a profession and stop using implants with known poor outcomes unless other data is published to change our minds,” Dr. Giddin said. “Moreover, we should continue to be careful about being encouraged into using other new implants until adequate long term follow-up is available.”
More Articles on Orthopedic Implants:
St. Jude Medical Recalls Pain Management Implant
Biomet Completes $1B Debt Offering
Mako Surgical Shareholders File Lawsuits Alleging Inflated Stock Prices
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
